Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15K Buy
16
+2
+14% +$188 ﹤0.01% 558
2026
Q1
$1.66K Hold
14
﹤0.01% 522
2025
Q4
$1.76K Buy
14
+8
+133% +$1.04K ﹤0.01% 552
2025
Q3
$878 Sell
6
-2
-25% -$302 ﹤0.01% 661
2025
Q2
$1.25K Sell
8
-8
-50% -$1.27K ﹤0.01% 505
2025
Q1
$2.63K Hold
16
﹤0.01% 422
2024
Q4
$2.61K Sell
16
-1
-6% -$179 ﹤0.01% 452
2024
Q3
$3.32K Buy
17
+1
+6% +$184 ﹤0.01% 401
2024
Q2
$2.77K Buy
16
+1
+7% +$166 ﹤0.01% 424
2024
Q1
$2.54K Hold
15
﹤0.01% 430
2023
Q4
$2.96K Buy
+15
New +$2.65K ﹤0.01% 394

Other funds holding ZTS

Aspect Partners's ZTS Position: Q2 2026 in Review

Aspect Partners increased its Zoetis (ZTS) stake by 14% in Q2 2026, buying an estimated $188 and bringing the position to 16 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #558.

Aspect Partners first reported a position in ZTS in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.32K in Q3 2024. 270 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Aspect Partners held 16 shares of Zoetis worth $1.15K as of Q2 2026.
  • Aspect Partners bought 2 Zoetis shares in Q2 2026, an estimated $188.
  • Zoetis made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #558 holding.
  • Aspect Partners first reported a position in Zoetis in Q4 2023 and has held it in 11 quarters since.
  • Aspect Partners's Zoetis position peaked at $3.32K in Q3 2024.
  • 270 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.